Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Oncology Letters
|
December 8, 2022
Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with <sup>99m</sup>Tc and <sup>125</sup>I
Vladimir Tolmachev, Vitalina Bodenko, Anna Orlova, et al.
EJNMMI Research
|
February 6, 2020
On the prevention of kidney uptake of radiolabeled DARPins
Mohamed Altai, Javad Garousi, Sara S Rinne, et al.
Oncology Reports
|
March 22, 2022
Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cells
Tianqi Xu, Yongsheng Liu, Alexey Schulga, et al.
Cancers
|
June 28, 2023
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [<sup>99m</sup>Tc]Tc-ADAPT6 and [<sup>99m</sup>Tc]Tc-(HE)<sub>3</sub>-G3, for Imaging of HER2-Positive Breast Cancer
Olga Bragina, Vladimir Chernov, Alexey Schulga, et al.
International Journal of Molecular Sciences
|
June 26, 2019
Indirect Radioiodination of DARPin G3 Using N-succinimidyl-<i>Para</i>-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging
Anzhelika Vorobyeva, Alexey Schulga, Sara S Rinne, et al.
Pharmaceutics
|
May 10, 2019
Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin
Evgeniya Sokolova, Olga Kutova, Alena Grishina, et al.
Molecules (Basel, Switzerland)
|
October 17, 2020
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
Anzhelika Vorobyeva, Ekaterina Bezverkhniaia, Elena Konovalova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 15, 2016
Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo
Evgeniya Sokolova, Galina Proshkina, Olga Kutova, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model
Tianqi Xu, Alexey Schulga, Elena Konovalova, et al.
International Journal of Molecular Sciences
|
May 13, 2020
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
Anzhelika Vorobyeva, Elena Konovalova, Tianqi Xu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Oncology Letters
|
December 8, 2022
Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with <sup>99m</sup>Tc and <sup>125</sup>I
Vladimir Tolmachev, Vitalina Bodenko, Anna Orlova, et al.
EJNMMI Research
|
February 6, 2020
On the prevention of kidney uptake of radiolabeled DARPins
Mohamed Altai, Javad Garousi, Sara S Rinne, et al.
Oncology Reports
|
March 22, 2022
Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cells
Tianqi Xu, Yongsheng Liu, Alexey Schulga, et al.
Cancers
|
June 28, 2023
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [<sup>99m</sup>Tc]Tc-ADAPT6 and [<sup>99m</sup>Tc]Tc-(HE)<sub>3</sub>-G3, for Imaging of HER2-Positive Breast Cancer
Olga Bragina, Vladimir Chernov, Alexey Schulga, et al.
International Journal of Molecular Sciences
|
June 26, 2019
Indirect Radioiodination of DARPin G3 Using N-succinimidyl-<i>Para</i>-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging
Anzhelika Vorobyeva, Alexey Schulga, Sara S Rinne, et al.
Pharmaceutics
|
May 10, 2019
Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin
Evgeniya Sokolova, Olga Kutova, Alena Grishina, et al.
Molecules (Basel, Switzerland)
|
October 17, 2020
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
Anzhelika Vorobyeva, Ekaterina Bezverkhniaia, Elena Konovalova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 15, 2016
Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo
Evgeniya Sokolova, Galina Proshkina, Olga Kutova, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model
Tianqi Xu, Alexey Schulga, Elena Konovalova, et al.
International Journal of Molecular Sciences
|
May 13, 2020
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
Anzhelika Vorobyeva, Elena Konovalova, Tianqi Xu, et al.
Page
of 3